The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Use of serum and tissue biomarker analysis embedded in a phase II clinical trial of cytarabine in castration-refractory prostate cancer to investigate prostate cancer biology.
J. Groskopf
Employment or Leadership Position - Gen-Probe
S. Niraula
No relevant relationships to disclose
U. Emmeneger
No relevant relationships to disclose
L. Adams
No relevant relationships to disclose
I. Tannock
No relevant relationships to disclose
S. S. Sridhar
No relevant relationships to disclose
J. J. Knox
No relevant relationships to disclose
J. R. Day
Employment or Leadership Position - Gen-Probe
J. Manthe
Employment or Leadership Position - Gen-Probe
A. M. Joshua
No relevant relationships to disclose